For laboratory research use only. Not for human or veterinary use. Sold to qualified researchers 21+. Research-use terms

Free standard shipping on orders $99+ Shop →

Compound reference

Semaglutide CAS, molecular weight and sequence reference

By · Published · updated · vendor-authored explanatory note

Short answer

Semaglutide is a 31-residue GLP-1 analogue with 2-aminoisobutyric acid at position 2 and an 18-carbon diacid side chain, attached through a linker, on lysine 20. PubChem CID 56843331 lists CAS 910463-68-2, formula C187H291N45O59, an average molecular weight of 4114 g/mol and a monoisotopic mass of 4111.1154 Da, so LC-MS identity checks look for higher charge states such as [M+4H]4+ at m/z 1028.79, [M+5H]5+ at m/z 823.23 and [M+6H]6+ at m/z 686.19. Research-grade semaglutide from this catalog is for laboratory research use only.

View research-grade Semaglutide in the catalog

Semaglutide identity data from PubChem CID 56843331 (retrieved 2026-11-19). Ion values are calculated, not measured on any lot.
PropertyValueNote
CAS number910463-68-2Free peptide as described in PubChem CID 56843331.
PubChem CID56843331Record title: Semaglutide.
Molecular formulaC187H291N45O59Includes the AEEA-AEEA-γ-Glu-C18 diacid side chain.
Average molecular weight4,114 g/molUse for mg-to-mole arithmetic.
Monoisotopic mass4111.1154 DaUse for high-resolution MS.
BackboneH-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(side chain)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OHAib at position 2; C-terminal acid, not amide.
Side chain on Lys20Nε-(AEEA-AEEA-γ-Glu-17-carboxyheptadecanoyl)The lipidated linker described by Lau et al. (2015).
Expected ESI ions (calc.)[M+4H]4+ m/z 1028.79; [M+5H]5+ m/z 823.23; [M+6H]6+ m/z 686.19A large peptide; look for a charge-state series, not only [M+H]+.

What distinguishes this structure

Lau et al. (2015) described semaglutide as a GLP-1 analogue designed for a long plasma half-life: 2-aminoisobutyric acid replaces alanine at position 2, and lysine 20 carries a diacid fatty-acid chain through two 8-amino-3,6-dioxaoctanoic acid (AEEA) spacers and a γ-glutamate. The C-terminus is a free acid (Gly), not an amide.

The side chain adds substantial mass and changes the formula relative to an unmodified 31-residue backbone. A certificate that reports only a short GLP-1 fragment mass is not describing this molecule. The comparison page on this site places semaglutide next to other incretin-class analogues by receptor class and mass; this page is the identity table for semaglutide itself.

Mass shifts worth knowing on an LC-MS report

Identity checks use the multiply charged envelope calculated from 4111.1154 Da. Counter-ions are lost in the source. A missing or incomplete side chain produces a much smaller intact mass than 4114 g/mol and will not sit on the 1028.79 / 823.23 / 686.19 series.

  1. Aib → Ala (−14.02 Da): a related analogue, not this molecule.
  2. Des-side-chain or truncated linker: a large downward mass shift; the 4+/5+/6+ ions above will be absent.
  3. +15.99 Da: oxidation (tryptophan and histidine are plausible sites).
  4. C-terminal amide instead of acid (−0.98 Da): easy to miss at low resolution.

Side-chain building blocks and the mass each one adds

Most of the difference between semaglutide and its plain 31-residue backbone sits in four pieces attached to the ε-amine of lysine 20. Knowing the residue mass of each piece makes it easy to see which part is missing when a chromatogram shows a related substance below the main peak. Values are monoisotopic residue masses (the free building block minus water), calculated from elemental formulas.

  1. AEEA spacer (8-amino-3,6-dioxaoctanoic acid), residue C6H11NO3: 145.07 Da each; semaglutide carries two, so a des-AEEA variant reads about 145 Da low.
  2. γ-Glutamate linker, residue C5H7NO3: 129.04 Da.
  3. 17-Carboxyheptadecanoyl (C18 diacid) acyl group, C18H33O3: 297.24 Da; losing the whole lipid chain removes far more mass than any single-residue change.
  4. Aib at position 2 (C4H7NO residue, 85.05 Da) versus Ala (71.04 Da): the −14.02 Da shift listed above.
  5. Aspartimide at Asp9 (−18.01 Da) and deamidation of Gln17 (+0.98 Da) are generic peptide degradation shifts worth checking against the impurity table on a certificate.

Lot documentation and ordering

No third-party lot report for Semaglutide is published on this site yet. A lab report is available on request for the lot you would receive, and the batch number on the vial can be checked on the lot lookup page. Only some lots have a published COA.

Self-serve orders from the United States (Canada and Mexico are paused) use US fulfillment and usually ship within 5 business days of confirmed payment. Credentialed laboratories in other eligible countries can request an institutional export review through the international lab orders page.

Frequently asked

What is the CAS number of semaglutide?

910463-68-2, per PubChem CID 56843331 (retrieved 2026-11-19).

What is the molecular weight of semaglutide?

4,114 g/mol average (C187H291N45O59) and 4111.1154 Da monoisotopic, including the Lys20 side chain.

What is the semaglutide sequence?

A 31-residue backbone His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH, with Aib at position 2 and an AEEA-AEEA-γ-Glu-C18 diacid chain on Lys20.

Which ions confirm semaglutide identity by LC-MS?

Calculated ions include [M+4H]4+ at m/z 1028.79, [M+5H]5+ at m/z 823.23 and [M+6H]6+ at m/z 686.19, from the PubChem monoisotopic mass 4111.1154 Da.

Is there a published COA for Semaglutide on this site?

Not yet. Only some lots have a published report. A lab report is available on request for the specific lot, and batch numbers can be checked on the lot lookup page.

Is research-grade Semaglutide a finished drug?

No. It is sold for laboratory research use only and is not for human or veterinary consumption.

References

  1. PubChem: Semaglutide (CID 56843331)CAS 910463-68-2, C187H291N45O59, 4114 g/mol, monoisotopic 4111.1154 Da (retrieved 2026-11-19).
  2. Lau J et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. J Med Chem 2015 (PMID 26174015)Describes the Aib substitution and the Lys20 diacid side chain.